HER-2 positive
- Business
Synaffix Sees Competitive Early In Vivo Data from ADCs Based on Proprietary Exatecan Linker-Payload
Amsterdam, Netherlands:Â In vivo efficacy on a par with gold standard deruxtecan-based ADCs Poster to be presented at World ADC…
Read More »